Saturday, July 11, 2026

pharma · Melanoma · Multiple Myeloma

Xijing Hospital

Xijing Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Melanoma, Multiple Myeloma, Stroke, Thyroid Cancer. NovaPharmaNews links 4 clinical program(s), 0 drug profile(s), and

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
4
Drugs
5
Patents
0
Clinical program

Folic Acid

Unknown · small molecule · Stroke

Folic Acid for Stroke is a Unknown program (small_molecule) at Xijing Hospital with 1 ClinicalTrials.gov record(s).

← All Xijing Hospital projects Unknown small molecule terminated

Internal code xijing-003

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Xijing Hospital
Phase
Unknown
Modality
small_molecule
Indication
Stroke
Status
terminated
Trials
1